Skip to main content

Find Clinical Trials

Home
Conditions
Fabry Disease

Clinical trial condition

Fabry Disease

Explore clinical trials studying Fabry Disease. Study availability and eligibility vary by location and protocol.

158 public trials 34 recruiting studies

Refine in advanced search Browse all conditions

Fabry Disease trial results

Completed

Androgenetic Alopecia in Fabry Disease

NCT01295008

Conditions: Alopecia, Brain Diseases, Brain Diseases, Metabolic, +26 more
Locations: Baylor University Medical Center Dallas, Texas, United States

View Trial Details

Completed

A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease

NCT00140621

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Fujita Health University Hospital Aichi, Japan

Sapporo Medical University Hospital Hokkaido, Japan

Akune Citizen Hospital Kagoshima, Japan

Tohoku University Hospital Miyagi, Japan

View Trial Details

Completed

A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.

NCT00233870

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Tohoku University Hospital Sendai, Japan

View Trial Details

Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

NCT00196716

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: II. interní klinika 1. LF UK Prague, Czechia

Tartu University Clinics, Department of Internal Medicine Tartu, Estonia

Klinika Chorob Metabolicznych, Instytut "Pomnik-Centrum Zdrowia Dziecka" Warsaw, Poland

Detská fakultná nemocnica Kramáre I. Interná klinika Bratislava, Slovakia

View Trial Details

Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

NCT00081497

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

University of San Francisco San Francisco, California, United States

University of Connecticut Health Partners West Hartford, Connecticut, United States

View all 25 locations

View Trial Details

Completed

A Study of Fabrazyme in Pediatric Patients With Fabry Disease

NCT00074958

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: University of Arizona Tucson, Arizona, United States

Hopital Edouard Herriot Lyon, France

Hopital de la Timone Enfants Marseille, France

Hopital Europeen Georges Pompidou Paris, France

View Trial Details

Completed

Dosing Study of Replagal in Patients With Fabry Disease

NCT00068107

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +33 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Sleepiness and Sleep-disordered Breathing in Fabry Disease. A Prospective Cohort Study.

NCT01947634

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: University Hospital Zurich, Division of Internal Medicine Zurich, Canton of Zurich, Switzerland

View Trial Details

Completed

Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients.

NCT01997489

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Ulla Feldt-Rasmussen Copenhagen, Capital Region, Denmark

National University Hospital, Department of Medical Endocrinology Copenhagen, Denmark

View Trial Details

Completed

A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta

NCT01650779

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Coral Springs, Florida, United States

Decatur, Georgia, United States

Baltimore, Maryland, United States

Grand Rapids, Michigan, United States

View Trial Details